Literature DB >> 29332261

Is the laser mightier than the sword? A comparative study for the urethrotomy.

Coen Holzhauer1, Anita W T M Roelofs2, Arjen C Kums2, Philip C Weijerman2, Michael R van Balken2.   

Abstract

PURPOSE: The knife is the most common used instrument for endoscopic urethrotomy. Unfortunately, there are high recurrence rates; it is thought that a laser reduces those rates. We compared the two techniques in this retrospective study.
MATERIALS AND METHODS: Between 2010 and 2014, 127 patients were operated on with the knife (KG) and for 65 patients, the laser (LG) was used. We scored the complexity of the stricture using the UREThRAL stricture score (USS) and we scored if a treatment was successful. A failure was determined as recurrence, but also starting clean intermittent catheterization was stated as failure.
RESULTS: There was no difference in USS between the two groups (KG: 5.7 vs LG: 6.0); the laser was more often used in a patient with a recurrence stricture (25.2 vs 43.1%). No difference was found in postoperative increase in flow-rate (9.5 vs 10.5 ml/sec), the number of complications (all Clavien I and one Clavien III in the KG) or the failure rate (58.3 vs 68.8%). When looked separately at patients treated for primary stricture and for a recurrence (96.7 vs 91.2%), no differences were found.
CONCLUSION: There were no significant differences between knife and laser. With costs taken in consideration, we would advise treatment with the knife. Our results also show a high failure rate, especially in the recurrence group. Therefore, in case of recurrence, an open reconstruction should be considered.

Entities:  

Keywords:  Endoscopic; Laser; Urethra stricture

Mesh:

Year:  2018        PMID: 29332261     DOI: 10.1007/s00345-018-2172-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  8 in total

1.  Low-power holmium:YAG laser urethrotomy for urethral stricture disease: comparison of outcomes with the cold-knife technique.

Authors:  Mustafa Atak; Hüsnü Tokgöz; Bülent Akduman; Bülent Erol; Ibrahim Dönmez; Volkan Hancı; Ozlem Türksoy; Necmettin Aydın Mungan
Journal:  Kaohsiung J Med Sci       Date:  2011-11       Impact factor: 2.744

2.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

3.  [Treatment of urethral stricture: transurethral slit in view using sharp section].

Authors:  H Sachse
Journal:  Fortschr Med       Date:  1974-01-10

4.  Male urethral stricture disease.

Authors:  Richard A Santucci; Geoffrey F Joyce; Matthew Wise
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

5.  The UREThRAL stricture score: A novel method for describing anterior urethral strictures.

Authors:  Lucas R Wiegand; Steven B Brandes
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

6.  Transurethral laser urethrotomy in man: preliminary report.

Authors:  H Bülow; U Bülow; H G Frohmüller
Journal:  J Urol       Date:  1979-03       Impact factor: 7.450

7.  Comparison of treatment results between holmium laser endourethrotomy and optical internal urethrotomy for urethral stricture.

Authors:  Slawomir A Dutkiewicz; Mariusz Wroblewski
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

Review 8.  Guidelines of guidelines: a review of urethral stricture evaluation, management, and follow-up.

Authors:  David B Bayne; Thomas W Gaither; Mohannad A Awad; Gregory P Murphy; E Charles Osterberg; Benjamin N Breyer
Journal:  Transl Androl Urol       Date:  2017-04
  8 in total
  1 in total

1.  Canadian Urological Association guideline on male urethral stricture.

Authors:  Keith F Rourke; Blayne Welk; Ron Kodama; Greg Bailly; Tim Davies; Nancy Santesso; Philippe D Violette
Journal:  Can Urol Assoc J       Date:  2020-10       Impact factor: 2.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.